Key facts
- Notable investors include BRYCK, Gründerfonds Ruhr, Science4Life, Twip Impact Ventures, Xpreneurs.
- Status: Privately Held (backing).
- ·The complete investor list — 5 names
- ·Watchlist + deal alerts for 2NA Fish
- ·The full record, as it builds
Funding rounds
No funding rounds for 2NA Fish are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About 2NA Fish
Developer of a platform technology designed to measure RNA (Ribonucleic Acid) biomarkers within their spatial context to support informed cancer research and treatment decisions. The company offers multiplex FISH (Fluorescence In Situ Hybridization)-based spatial transcriptomics capabilities, enabling cancer researchers to examine RNA distribution across tissue samples to guide therapy selection and reduce ineffective treatments and related risks.
- Sector
- Healthcare
- HQ
- Munich, Germany
- Founded
- 2024
- Employees
- 7
- Website
- 2nafish.bio/
- Ownership
- Privately Held (backing)
2NA Fish doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in 2NA Fish shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on 2NA Fish in its N-PORT filings yet. We sweep new filings monthly.